A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK.
Saved in:
| Title: | A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. |
|---|---|
| Authors: | Vyse A; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Campling J; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Czudek C; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Ellsbury G; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Mendes D; Health & Value, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Reinert RR; Medical Affairs, Pfizer Inc, Paris, France., Slack M; School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Queensland 4222, Australia. |
| Source: | Expert review of vaccines [Expert Rev Vaccines] 2021 Oct; Vol. 20 (10), pp. 1311-1325. Date of Electronic Publication: 2021 Oct 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8395 |
|---|---|
| DOI: | 10.1080/14760584.2021.1984888 |
